Biomarker-guided rTMS for Treatment Resistant Depression
Recruiting · 2 sites across 2 states
Always free
Study care at no cost to you
For your time and travel
Many studies pay you back
Most need no insurance or papers
Legal status usually isn't required; we'll tell you each study's requirements
Interpreters available
Ask for your language
Your choice
Voluntary — you can stop anytime
What is this study?
Repetitive transcranial magnetic stimulation (rTMS) is a treatment for depression. The investigators are continuing to learn how to optimize outcomes from rTMS treatment.
It is , overseen by an independent and licensed medical staff.
Read the full clinical description
Repetitive transcranial magnetic stimulation (rTMS) is a treatment for depression. The investigators are continuing to learn how to optimize outcomes from rTMS treatment. The purpose of this research project is to use brain network connectivity patterns as measured by resting state functional magnetic resonance imaging (fMRI) to confirm a way to optimize the use of rTMS to treat depression. In addition, the study aims to gain a better understanding of how rTMS influences brain networks.
Who this study is looking for
In plain language, from the study's own rules. The study team confirms the full details with you — this isn't a final yes or no.
✅ You may be able to join if…
- •Age 22 to 65.
- •Have Major Depressive Disorder (MDD) as checked by a licensed study psychiatrist or psychologist.
- •Depression must be at least moderately severe (Hamilton Depression Rating Scale score ≥ 18).
- •Have not responded in this current episode to at least 1 antidepressant taken at an adequate dose and for an adequate time (treatment resistance is also measured with the Maudsley Staging Method).
- •Can consent, can do MRI safely, and are fluent in English.
🚫 You may not be able to join if…
- •Imminent risk of suicide (based on the Columbia-Suicide Severity Rating Scale).
- •Current depressive episode lasts 2 years or more.
- •Have other primary psychiatric diagnoses besides MDD, or have comorbid generalized anxiety disorder or phobia listed as allowed comorbid diagnoses is not specified—other primary psychiatric diagnoses are excluded (examples include PTSD, OCD, psychotic features, primary psychotic illness, Bipolar I or II).
- •Have certain brain/nerve problems (examples include stroke, Parkinson’s disease/movement disorder, epilepsy or seizure history, major head trauma, dementia, tumors in the brain/central nervous system).
- •Cannot have MRI safety barriers like implanted electronic devices/metal/conductive objects near the head.
Are you a good fit?
Simplified highlights. The study team always confirms the full details with you.
- ✓Adults roughly 22–65
- ✓Have Depression
- !Some conditions may not be a fit: Anxiety
- !Not for people who are pregnant or breastfeeding
What to expect, step by step
- 1
Usually a few weeks
The study team checks whether the study is a good fit for you, with a visit and sometimes lab tests. You can ask any questions before deciding.
- 2
Treatment
If you join and choose to continue, you receive the study treatment and are watched closely by medical staff.
- 3
Follow-up
After treatment, the team checks on your health and confirms the visit schedule with you. You can leave the study at any point.
Has this treatment been tested before?
Yes. This treatment has already been through earlier human studies for safety before reaching this stage.
What you need to know before you apply
What is this study testing?+
Repetitive transcranial magnetic stimulation (rTMS) is a treatment for depression. The investigators are continuing to learn how to optimize outcomes from rTMS treatment.
Is it safe? Who makes sure of that?+
This is a late-stage study (Phase 3), testing how well the treatment works in more people. Every study is reviewed and monitored by an independent ethics board (called an IRB) whose job is to protect participants, and care is overseen by licensed medical staff. You'll be told the known risks before you agree to anything, and you can stop at any time.
Will I get a placebo instead of the real treatment?+
Some studies compare a treatment against a placebo (an inactive version), and some don't. If this one does, the study team will explain your chances of receiving the active treatment before you decide. Nothing is hidden from you.
Do I have to stop taking my current medications?+
It depends on the study. Some let you stay on your current medications and some ask you to adjust them. Never stop a medication on your own — the study team will review everything with you first.
Does it cost anything? Will I be paid?+
Study-related care is provided at no cost to you. Some studies also pay for your time; the coordinator can tell you if this one does. You should never be asked to pay to take part.
Do I need insurance? Will anyone ask about my immigration status?+
No. You do not need health insurance to take part in a research study, and you will not be asked about your immigration status to join. Taking part is about whether you're a medical fit for the study.
What if English isn't my first language?+
You have the right to understand everything before you agree. Study sites can often provide materials or an interpreter in your language — you can ask the coordinator for one.
Is my information private?+
Yes. Your health information is only shared with the study sites you choose to be contacted by, and only to help match and enroll you. It is never sold, and you can ask us to delete it at any time.
Some requirements (like specific lab values or timing) are confirmed directly by the study team, not by us.
Source: ClinicalTrials.gov · NCT04041479 · Locations: California · New York